Skip to main content
. Author manuscript; available in PMC: 2016 Apr 12.
Published in final edited form as: Diabetes Metab Res Rev. 2015 Jan;31(1):39–49. doi: 10.1002/dmrr.2542

Figure 2.

Figure 2

Western blot analysis and quantitative data (n=5), in homogenized aorta from control and type 2 diabetic mice (db/db) treated with or without DHMEQ or IKK-NBD, showing phosphorylated P-eNOS, total T-eNOS (A) phosphorylated P-p-65, total T-p-65 (B), cleaved c-PARP-1 and total T-PARP-1 (C), COX-2 (D) and β-actin. $P< 0.05 for db/db vs. control, control treated with DHMEQ or IKK-NBD, db/db treated with DHMEQ or IKK-NBD.

@P< 0.05 for db/db vs. db/db treated with DHMEQ or IKK-NBD